Form 4: AMN Healthcare Officer's Routine Stock Transactions

AMN Healthcare's Chief Information and Digital Officer, Mark C. Hagan, reported the vesting and acquisition of Restricted Stock Units and subsequent share disposals for tax purposes.

Summary

• Mark C. Hagan, Chief Information and Digital Officer of AMN Healthcare Services Inc., reported multiple transactions on January 15, 2026.
• Hagan acquired a total of 10,313 shares of AMN Common Stock through the vesting of Restricted Stock Units (RSUs) from grants made in 2023, 2024, and 2025.
• Concurrently, 4,139 shares were disposed of at a price of $19.55 per share to cover tax obligations related to the RSU vesting.
• Following these transactions, Hagan's direct beneficial ownership of common stock increased to 44,873 shares.
• Additionally, Hagan was granted 36,828 new Restricted Stock Units under the AMN Healthcare 2025 Equity Plan, bringing his total beneficial ownership of derivative securities (RSUs) to 73,656.

Sentiment

Score: 5

Explanation: This Form 4 reports standard executive compensation activities, including the vesting of Restricted Stock Units, subsequent share disposals for tax purposes, and a new RSU grant. These are routine events and do not indicate any significant positive or negative operational or financial developments for the company.

Positives

• The vesting of 10,313 Restricted Stock Units demonstrates the continued realization of long-term incentive compensation for a key executive.
• The grant of 36,828 new Restricted Stock Units aligns the executive's interests with long-term shareholder value creation and indicates ongoing commitment to the company.
• The increase in direct beneficial ownership of common stock to 44,873 shares after vesting and tax withholding shows a net increase in the executive's equity stake.

Negatives

• A total of 4,139 shares were disposed of to cover tax liabilities, which is a standard practice but reduces the executive's immediate direct shareholding.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook, as it is a report of individual insider transactions.

Industry Context

The reported transactions are typical for executive compensation structures in publicly traded companies, involving the vesting of equity awards and subsequent share disposals to cover tax obligations. This is a standard mechanism for aligning executive incentives with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a common practice across various industries, including healthcare staffing and solutions.
• The vesting schedule of RSUs in tranches over several years is a standard approach to promote long-term executive retention and performance.
• The disposal of shares to cover tax withholding upon RSU vesting is a routine and widely accepted practice for equity compensation, consistent with industry benchmarks.

Stakeholder Impact

• Shareholders: The transactions reflect routine executive compensation, aligning management's long-term interests with shareholder value through equity ownership. No direct material impact on share price is expected from these routine transactions.
• Employees: No direct impact on general employees is indicated by this executive compensation filing.

Next Steps

• Future tranches of the newly granted 36,828 Restricted Stock Units will vest on the first, second, and third anniversaries of the January 15, 2026 grant date.
• Remaining tranches of RSUs granted on January 15, 2024 (2,317 units) and January 15, 2025 (13,467 units) will vest on their respective future anniversary dates.

Key Dates

Keywords

AMN Healthcare, Form 4, insider trading, stock transactions, RSU, restricted stock units, executive compensation, Mark C. Hagan